Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection
Open Access
- 5 March 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3), 342
- https://doi.org/10.3390/pharmaceutics13030342
Abstract
Inhaled administration of ethanol in the early stages of COVID-19 would favor its location on the initial replication sites, being able to reduce the progression of the disease and improving its prognosis. Before evaluating the efficacy and safety of this novel therapeutic strategy in humans, its characterization is required. The developed 65° ethanol formulation is stable at room temperature and protected from light for 15 days, maintaining its physicochemical and microbiological properties. Two oxygen flows have been tested for its administration (2 and 3 L/min) using an automated headspace gas chromatographic analysis technique (HS-GC-MS), with that of 2 L/min being the most appropriate one, ensuring the inhalation of an ethanol daily dose of 33.6 ± 3.6 mg/min and achieving more stable concentrations during the entire treatment (45 min). Under these conditions of administration, the formulation has proven to be safe, based on histological studies of the respiratory tracts and lungs of rats. On the other hand, these results are accompanied by the first preclinical molecular imaging study with radiolabeled ethanol administered by this route. The current ethanol formulation has received approval from the Spanish Agency of Medicines and Medical Devices for a phase II clinical trial for early-stage COVID-19 patients, which is currently in the recruitment phase (ALCOVID-19; EudraCT number: 2020-001760-29).Funding Information
- Instituto de Salud Carlos III (JR18/00014, CM18/00090, CM/00135, CM20/00024)
- Ministerio de Ciencia e Innovación (IJCI-2017-31665)
- Ministerio de Economía y Competitividad (RYC- 2015/17430)
This publication has 48 references indexed in Scilit:
- Assessment of Exposure to Alcohol Vapor from Alcohol-Based Hand RubsInternational Journal of Environmental Research and Public Health, 2012
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Vapor Inhalation of Alcohol in RatsCurrent Protocols in Neuroscience, 2008
- Biodistribution of Radiolabeled Ethanol in RodentsDrug Metabolism and Disposition, 2008
- Use of Ethanol Lock Therapy to Reduce the Incidence of Catheter‐Related Bloodstream Infections in Home Parenteral Nutrition PatientsJournal of Parenteral and Enteral Nutrition, 2007
- Transport and Uptake of MTBE and Ethanol Vapors in a Human Upper Airway ModelInhalation Toxicology, 2006
- Injection of alcohol to control bleeding from ruptured hepatomas.BMJ, 1990
- Pain relief in active patients with cancer: the early use of nerve blocks improves the quality of life.BMJ, 1989
- Endoscopic sclerotherapy using absolute alcohol.Gut, 1985
- Long-term ethanol administration methods for rats: advantages of inhalation over intubation or liquid dietsBehavioral and Neural Biology, 1979